About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Clcn7tm1.1Mawa
targeted mutation 1.1, Matthew Warman
MGI:5882799
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Clcn7tm1.1Mawa/Clcn7tm1.1Mawa involves: C57BL/6J * C57BL/6N * CD-1 MGI:6259525
ht2
Clcn7tm1.1Mawa/Clcn7+ involves: C57BL/6J * C57BL/6N * CD-1 MGI:6259526
ht3
Clcn7tm1.1Mawa/Clcn7tm1.1Mjec involves: 129 * C57BL/6J * C57BL/6N * CD-1 MGI:6259533


Genotype
MGI:6259525
hm1
Allelic
Composition
Clcn7tm1.1Mawa/Clcn7tm1.1Mawa
Genetic
Background
involves: C57BL/6J * C57BL/6N * CD-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Clcn7tm1.1Mawa mutation (1 available); any Clcn7 mutation (42 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice die around 1 month of age

growth/size/body
• mice do not have toot eruption
• mice are runted and are smaller at 3 weeks of age

skeleton
• mice do not have toot eruption
• 3 week old mice exhibit greater bone mineral density

craniofacial
• mice do not have toot eruption




Genotype
MGI:6259526
ht2
Allelic
Composition
Clcn7tm1.1Mawa/Clcn7+
Genetic
Background
involves: C57BL/6J * C57BL/6N * CD-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Clcn7tm1.1Mawa mutation (1 available); any Clcn7 mutation (42 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
• males exhibit more osteoclasts per bone perimeter and surface area indicating increased osteoclast number
• interferon-gamma therapy decreases osteoclast number
• males show a slight increase in bone mineral density at 12 weeks of age
• mice exhibit an increase in trabecular bone volume fraction
• interferon-gamma therapy from 4-12 weeks of age does not reduce trabecular bone volume
• males exhibit a decrease in cortical area fraction
• males exhibit a decrease in cortical thickness
• females exhibit an increase in trabecular thickness
• males, but not females, show a decrease in energy to ultimate force in the three-point bending assay, indicating decreased bone strength

hematopoietic system
• males exhibit more osteoclasts per bone perimeter and surface area indicating increased osteoclast number
• interferon-gamma therapy decreases osteoclast number

immune system
• males exhibit more osteoclasts per bone perimeter and surface area indicating increased osteoclast number
• interferon-gamma therapy decreases osteoclast number

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
autosomal dominant osteopetrosis 2 DOID:0110938 OMIM:166600
J:254787




Genotype
MGI:6259533
ht3
Allelic
Composition
Clcn7tm1.1Mawa/Clcn7tm1.1Mjec
Genetic
Background
involves: 129 * C57BL/6J * C57BL/6N * CD-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Clcn7tm1.1Mawa mutation (1 available); any Clcn7 mutation (42 available)
Clcn7tm1.1Mjec mutation (0 available); any Clcn7 mutation (42 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice die by around 1 month of age

growth/size/body
• mice are runted

skeleton

craniofacial





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/05/2024
MGI 6.24
The Jackson Laboratory